key: cord-0698478-se521t2j authors: Fuseini, Kamil; Jarvis, Leah; Ankomah, Augustine; Bintou Mbow, Fatou; Hindin, Michelle J. title: Did COVID‐19 Impact Contraceptive Uptake? Evidence from Senegal date: 2022-04-18 journal: Stud Fam Plann DOI: 10.1111/sifp.12195 sha: 3df20aab15131163f39c1d7ae24774c22156f294 doc_id: 698478 cord_uid: se521t2j This study assessed the impact of the COVID‐19 pandemic on the number of new contraceptive acceptors in Senegal overall and by method. Monthly service data from March 2019 to December 2020 were extracted for the number of new contraceptive users of IUDs, implants, injectables, and oral contraceptive pills (OCPs). Data were analyzed using descriptive statistics and interrupted time series analysis for trend analyses overall and by the contraceptive method. Following the announcement of the first COVID‐19 case in Senegal in March 2020, there was an immediate significant decrease in the number of new acceptors overall, and for new users of implants and injectables. From March–December 2020, the trend in monthly new family planning acceptors increased overall, mainly driven by significant increases in new IUD and implant acceptors. Compared to the period before the onset of COVID‐19, there was a statistically significant shift from shorter‐acting methods (OCPs, injectables) to long‐acting reversible methods (IUDs, implants). Despite the immediate adverse impact of COVID‐19‐related restrictions, the number of new acceptors rebounded, trends in the number of new monthly acceptors significantly increased, and there was a significant shift to longer‐acting methods. Health systems can be subject to major disruptions in service provision caused by external factors-changes in political leadership, armed conflict, extreme weather events, or disease outbreaks such as Ebola, Zika, and the current COVID-19 pandemic. How well a health system can provide continuous services despite such a disruption will depend on the nature of the crisis and contextual and system-level factors (Hanefeld et al. 2018) . Contraceptive ser- (3.8 percent) and Kenya (14.4 percent) that reported pandemic-related reasons for nonuse . However, some recent evidence has indicated that the impact of the COVID-19 pandemic on contraception access and use has not been as drastic nor as long-lasting as initially feared. Contraception use has in fact increased among some women in need, such as among nulliparous women in rural Kenya and urban Burkina Faso ). An analysis of data on utilization of contraceptive health services by women referred via community health promoters in two regions of Mozambique showed a moderate, short-term decrease in service provision and utilization in the early stages of the pandemic; however, this was followed by a rebound to prepandemic service levels within a few months (Leight et al. 2021) . Lesser than feared impacts of the pandemic on contraceptive use may have in part been due to service delivery approaches adapted to minimize the impact on service availability and accessibility. Telehealth-or the practice of using communications that do not require in-person contacts, such as phone or video calls, WhatsApp, and text messages to provide counseling and services-has gained popularity and widespread use globally, accelerated by the pandemic (Nanda et al. 2020; Oyediran, Makinde, and Adelakin 2020). The increased use of self-care methods, including Sayana Press, pills, and condoms, has also been proposed, as well as the practice of providing more commodities at each visit, reducing the number of visits needed ). From 2010 to 2019, there has been a general upward trend in the prevalence of modern contraceptive use among all Senegalese women, aged 15-49 (The DHS Program n.d.) . According to the 2019 DHS, among all women, the most commonly used modern method was implants (7.0 percent), followed by injectables (5.6 percent), and oral contraceptive pills (OCP) (2.8 percent). Compared with modern contraceptive users in 2015 DHS, method use has been relatively stable with the overall rise in the prevalence of modern contraceptive use in 2019 is explained by primarily by an increase in implant use (3.8 percent in 2015, 7.0 percent in 2019). Despite recent progress in the prevalence of modern contraceptive use, approximately one in five Senegalese women have an unmet need for contraception, and 28 percent report contraceptive discontinuation within the first year of use (The DHS Program n.d). For their current method, the large majority of the implant (96.0 percent), injectable (94.4 percent), IUD (89.9 percent), and OCP (82.2 percent) users obtained their method from the public sector. Among public sector sources of contraceptives, health posts were the most used source, followed by a government health center. Among women who reported condom use, the majority obtained them from the private sector (66.2 percent), specifically from pharmacies (The DHS Program n.d.) . Among current users, 8 percent of Senegalese women obtained their most recent method from a pharmacy, while most women obtained their method from the public sector including a government health post (64 percent), health center or clinic (15 percent), or government hospital (6 percent) (Mallick et al. 2020 ). Senegal was one of the first West African countries to officially report a case of COVID-19, on March 2, 2020. On March 23, the Government declared a state of emergency, which sought to  Did COVID- Impact Contraceptive Uptake? limit interurban movement of people and goods at certain times, temporarily closed schools, and imposed a curfew throughout the country. From May 29, 2020, a subsequent order somewhat loosened restrictions: although there was a continued ban on gatherings in some public places such as theaters, bars, beaches, and sports grounds, people could gather in other public places including restaurants, markets, and places of worship. The order required people gathering in such spaces to wear masks, practice social distancing and wash or disinfect hands. The State of Emergency was extended three times and lasted until June 30, 2020 (République du Sénégal: Ministère de l'Economie du Plan et de la Coopération 2020). As major lockdowns were lifted, the government of Senegal continued public information campaigns to limit the spread of COVID-19 while simultaneously bolstering efforts to provide safe family planning (FP) and reproductive, maternal, newborn, child, and adolescent health (RMNCAH) care to women in Senegal (Ndiaye and Thioye 2020) . In the context of COVID-19 in Senegal, this study seeks to understand whether and to what extent the COVID-19 pandemic and related lockdowns affected women's uptake of contraception for the first time. Using district-level health monitoring information systems data, we explored the temporal trends in new contraceptive users for 12 months before the first COVID-19 case in March 2020, and for 10 months afterward, through December 2020. We also examine the trends in the method mix for the 22-month period. Data for this study were extracted from Senegal's District Health Information System 2 (DHIS2), a nationwide health information data capture system based on data aggregated from public health facilities (DHIS2 n.d.). Senegal's DHIS2 includes service data on modern contraceptive methods available at public health facilities including IUDs, implants, injectables, condoms, and OCPs. Service delivery data are recorded at the facility level and then entered into the DHIS2 system by public health facility staff. Data are recorded for indicators including new and continuing FP users, FP counseling, contraceptive discontinuation, and others, by FP method and by patients' ages. For this analysis, we used data on the number of new FP acceptors, based on the number of women who are using FP for the very first time and received an IUD, implant, injectable, or OCPs. While data are available for "continuing users" these data are not collected each month. Instead, the number of continuing users is based on estimated continued use. For example, a woman who gets a five-year implant is counted as a continuing user for five years. However, there is no information on whether she had the implant removed. With the potential for overestimation of use, we opted to only include new users in our analysis. Additionally, while condoms are included in DHIS2, most women who report condom use obtain them from pharmacies (The DHS Program n.d.) . Given the likely significant underestimation of condom users, we have excluded them from the current analysis. Monthly data on new users were extracted and aggregated from March 2019 through December 2020 providing trend information for 12 months prior to the announcement of the first case of COVID-19 in Senegal (March 2019 to February 2020) and for 10 months following the onset -19 (March 2020 to December 2020 . This study used anonymous secondary data aggregated to the population level; thus Institutional Review Board (IRB) approval was not required. Our analysis was conducted in several phases. First, we performed quality checks on the data extracted from DHIS2, aggregated the data on new users, and created summary statistics on new acceptors overall and bymethod. Next, we descriptively analyzed trends in the number of new acceptors, overall and by method, conducting chi-square to test for significant differences in method mix. We then conducted interrupted time series (ITS) analysis to estimate both the immediate and longer-term impact of COVID-19 on the number of new acceptors, overall, and by method. ITS segmented ordinary least square regression models were estimated to assess the impact of COVID-19 and related lockdowns on the number of new FP acceptors using the onset month of March 2020 as the "intervention". The period of March 2019-February 2020 is the preintervention period as provides the "counterfactual" estimate. Due to model fit and evidence of autocorrelation (data not shown), we chose to use Prais-Winsten models to account for the autocorrelation observed in the data (Prais and Winsten 1954) . To adjust for the potential effect of seasonality in contraceptive uptake, we used moving averages for smoothing. Postintervention linear trends were estimated for all ITS models. We also tested the robustness of our results by region (data not shown). The ITS regression model (single group) takes the form: where Y is the count of new users each month, (T). β 0 represents the intercept or starting level of the outcome variable (estimated number of new FP acceptors in March 2019). β 1 estimates the average monthly change in the number of new FP acceptors until the onset of the intervention or the counterfactual slope (March 2019 to February 2020). T t is the time (in months) since the start of the study, β 2 represents the change in the number of new FP users that occurred in March 2020 with the beginning of the COVID-19 pandemic, and β 3 represents the difference between the trend in new FP acceptors before the first announced case of COVID-19 compared to the trend in the number of new FP acceptors following the initial case. X t is a dummy (indicator) variable representing the event (pre-event periods 0, otherwise 1), X t T t is an interaction term between the event and time, and t the random error term. Data were unweighted and analyzed using Stata version 16 (StataCorp 2019). Table 2 shows the results of the ITS analysis for new FP acceptors (IUD, implants, injectables, and pills) over the 12 months preceding the first COVID-19 case in Senegal (March 2019 to February 2020), and the 10 months after the first case (March to December 2020). The difference between the trends in the prepandemic period and postpandemic onset period was not significant (96.5, p = 0.64, 95 percent CI: −334.7 to 527.7). These results are shown visually in Figure 1 . Table 3 shows the results of the national-level ITS analysis by the FP method. Before the first case of COVID was announced in Senegal, the trend in new FP acceptors was not significantly increasing or decreasing, with the exception of implants where there was an average increase of 205. Table 1 , with a method mix shifting to longer-acting methods. Figure 2 provides a visual display of the results in Table 3 . Our examination of trends in new FP acceptors from March 2019 to December 2020 shows a significant but short-lived disruption in new users occurring with the immediate onset and lockdown period of COVID-19 in Senegal in March 2020. In the longer pandemic period, through the rest of 2020, overall trends in new FP acceptors do not appear to have been significantly negatively impacted by COVID-19 when compared to the pre-pandemic period. On the contrary, the overall number of new FP acceptors significantly increased from March to December. This indicates that with the first COVID-19 case being announced, the onset of a period of strict lockdown on movement, and widespread fear-FP services were impacted. Women may have been unable or unwilling to access health facilities, or facilities and providers may have diverted resources away from FP toward services deemed more essential. In addition to our findings about new FP acceptors overall, we find that there was a significant shift in method mix following the start of the pandemic, with proportionally more new users opting for LARCs over short-acting methods compared with the prepandemic period. There was a shift toward more LARCs in the overall method mix, and a significant increase in xxxx  Studies in Family Planning () Did COVID- Impact Contraceptive Uptake? new IUD and implant acceptors in March-December 2020, while for the two shorter-acting methods, injectables and OCPs, there was a shift away from these methods, compared to before the pandemic. This may reflect a shift in fertility preferences, a preference for obtaining methods from other sources, or a desire to minimize the number of facility visits by obtaining a method that does not require frequent resupply. A previous study from Burkina Faso and Kenya showed that while most women did not shift their contraceptive use in the early months of the pandemic, women who did switch methods were more likely to adopt a more effective method . While women who use OCPs primarily obtain them from health facilities, they are also widely available in pharmacies. However, Senegalese law highly regulates activities in which pharmacists can engage and stipulates that they cannot engage in medical procedures such as injections, nor can they provide OCPs without a prescription (Mbow et al. 2018; Peterson et al. 2019) . A 2019 survey of pharmacies and clients in urban districts of Senegal showed that while most surveyed private facilities stocked OCPs and injectables, few current users surveyed obtained their method from a pharmacy (Peterson et al. 2019) . We are not able to show whether women who would have wanted to start using OCPs or injectables obtained them outside the public health facilities, such as in a private pharmacy, opted for another method, or did not start using a method at all. A mixed methods study in Senegal of short-term method users showed that 30 percent of women experienced delays in getting resupply of OCPs and injectables, and the reasons for these delays included health system barriers (cost of FP and availability of methods) as well as individual characteristics (covert use and illiteracy) (Cavallaro et al. 2018) . Such factors may have contributed to the shift to LARCs among new users who may have not wanted to consider repeated visits to the facilities, especially during the pandemic. There are several important limitations to this work. First, the DHIS2 data represent only public facilities and do not include data from pharmacies or private facilities. Without these data, it is not possible to get a complete picture of all new acceptors. We also do not have any data on quality of care, method availability, and whether women who came in for a specific method got their method of choice. Additionally, new acceptors do not include women who are switching methods or seeking refills of methods, and it is likely that most women who comprise modern contraceptive users are not new users. However, new users are an important focus, as they often face more hurdles to obtaining a method than continuing users. For some months, we have evidence of high data quality for the DHIS2; however, we were unable to assess data quality for all months of data, and data entry at the height of restricted movement could have been adversely impacted. Despite these limitations, we find that the COVID-19 pandemic significantly affected the initiation of contraceptive use from public health facilities at the beginning of the outbreak in Senegal, but that initiation of contraceptive use recovered in the ensuing months to prepandemic levels as has been found in other studies. Legal restrictions in Senegal on FP method provision in pharmacies, including injectables, provide some unique challenges to increasing access to contraceptive methods outside of public health facilities, making contraceptive users vulnerable. Approaches such as task shifting, where community health workers and pharmacists offer more methods, should be explored in Senegal, despite legal and policy barriers, as evidence from others, settings have shown feasibility (Prata et al. 2011; Hoke et al. 2012; Mané, Diop, and RamaRao 2015; Cover et al. 2017; Burke et al. 2018; Hernandez et al. 2018 ). Self-care options such as self-injection of Sayana Press have also been shown to be acceptable in other settings (Cover et al. 2017; Burke et al. 2018; Nai et al. 2020) . These approaches may also provide more equitable access for women who cannot easily access a public health facility. Providing a legal framework in which additional professionals such as pharmacists can provide some FP methods can help ensure uninterrupted access to methods when crises disrupt regular sources. Though our study was not able to examine the impact of socioeconomic or geographic factors on access to FP, COVID-19 has highlighted inequities in health systems and access to care globally, and barriers to accessing care, including FP, are likely to have disproportionately affected poor and marginalized women (Gilson et al. 2020 ). There is a critical need for women to be able to continue to access FP, including during health crises (FP2020 2020; World Health Organization 2020b), and additional research is needed to better understand which women were unable to access contraception and why, and to document the full impact of the pandemic on reproductive health outcomes. Studies in Family Planning () Did COVID- Impact Contraceptive Uptake? Health crises such as the COVID-19 pandemic can have a significant effect on the provision of essential preventative health care, including FP. Despite contraception is an essential medical service, we repeatedly find that provision of contraception can be easily disrupted. While there are reasons for optimism in terms of longer-term indications of health system recovery, women who were not able to access contraception during the initial COVID-19 lockdowns may have experienced unwanted or mistimed pregnancies and births. Shifts in the method mix toward a greater reliance on LARCs after the pandemic onset may indicate that women want to be able to use the longer term, more reliable methods, in particular in times of crisis. Policy change is needed in Senegal to expand options to contraception that include a larger number of venues where women can obtain methods, as well as a broadening of personnel who can provide a range of methods in the private sector. Such efforts could provide Senegalese women with more options, particularly when health systems are challenged, as they have been by the COVID-19 pandemic. The service statistics from DHIS2 were provided by the Ministry of Health of Senegal and are not publicly available. Family Planning during and after the West African Ebola Crisis Client and Provider Experiences with Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Malawi Effect of the 2014/2015 Ebola Outbreak on Reproductive Health Services in a Rural District of Guinea: An Ecological Study Understanding 'Missed Appointments' for Pills and Injectables: A Mixed Methods Study in Senegal Acceptability of Contraceptive Self-Injection with DMPA-SC among Adolescents in Gulu District, Uganda The Impact of the COVID-19 Crisis on Meeting Needs for Family Planning: A Global Scenario by Contraceptive Methods Used About DHIS2 Access to Contraception Is Critical in COVID-19 Response: FP2020 Statement What Role Can Health Policy and Systems Research Play in Supporting Responses to COVID-19 That Strengthen Socially Just Health Systems? Towards an Understanding of Resilience: Responding to Health Systems Shocks Task-Shifting the Provision of DMPA-SC in the DR Congo: Perspectives from Two Different Groups of Providers Community-Based Provision of Injectable Contraceptives in Madagascar: 'Task Shifting' to Expand Access to Injectable Contraceptives COVID-19 Pandemic Cuts Access to Sexual and Reproductive Healthcare for Women around the World Reproductive Health Care in the Time of COVID-19: Perspectives of Poor Women and Service Providers from Rahim Yar Khan, Punjab Contraceptive Dynamics during COVID-19 in Sub-Saharan Africa: Longitudinal Evidence from Burkina Faso and Kenya Short-Term Effects of the COVID-19 State of Emergency on Contraceptive Access and Utilization in Mozambique Contraceptive Use, Method Mix, and Method Availability: A Multilevel Analysis Task Sharing in the Delivery of Family Planning Programs : Experiences from Senegal Stories from the Frontline: In the Shadow of the COVID-19 Pandemic Exploration Du Rôle Potentiel Des Pharmacies Privées Dans l' offre de Services de Planification Familiale Au Sénégal: Revue Documentaire Sur Les Aspects Juridiques Introduction of DMPA-SC Self-Injection in Ghana: A Feasibility and Acceptability Study Using Sayana® Press Contraception in the Era of COVID-19 Senegal: A Leader in Access to FP/RH Care During COVID-19 The Role of Telemedicine in Addressing Access to Sexual and Reproductive Health Services in Sub-Saharan Africa during the COVID-19 Pandemic Over the Counter: The Potential for Easing Pharmacy Provision of Family Planning in Urban Senegal Provision of Injectable Contraceptives in Ethiopia through Community-Based Reproductive Health Agents Impact of Ebola Outbreak on Reproductive Health Services in a Rural District of Sierra Leone: A Prospective Observational Study Recueil Des Principaux Textes Émis Depuis Le Début de La Crise Sanitaire Liée à La COVID-19 -Exposé Des Textes Estimates of the Potential Impact of the COVID-19 Pandemic on Sexual and Reproductive Health in Low-and Middle-Income Countries Counting Indirect Crisis-Related Deaths in the Context of a Low-Resilience Health System: The Case of Maternal and Neonatal Health during the Ebola Epidemic in Sierra Leone Stata Statistical Software: Release  STATcompiler Impact of the COVID-19 Pandemic on Family Planning and Ending Gender-Based Violence, Female Genital Mutilation and Child Marriage Doing Things Differently: What It Would Take to Ensure Continued Access to Contraception during COVID-19 Need for and Use of Contraception by Women before and during COVID-19 in Four Sub-Saharan African Geographies: Results from Population-Based National or Regional Cohort Surveys In: Pulse Survey on Continuity of Essential Health Services during the COVID- Pandemic Maintaining Essential Health Services: Operational Guidance for the COVID-19 Context." World Health Organization Second Round of the National Pulse Survey on Continuity of Essential Health Services during the COVID-19 Pandemic The authors would like to acknowledge Dr. Anta Diaw, Health and Social Information System Division of the Ministry of Health and Social Action, Dakar, Senegal, for helping to obtain the data that were used for this research. This work was supported by the William and Flora Hewlett Foundation under Grant 2019-9151.